Roche DAT immunoassay: Sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid

Journal of Analytical Toxicology

Volumn 34, Issue 2, 2010, Pages 103-109

  Crooks, C Richard ^a   Brown, Sue ^a  

^a Kroll Laboratory Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZOYLECGONINE; COCAINE; METHAMPHETAMINE; OPIATE DERIVATIVE; CODEINE; MORPHINE; OPIATE;

ARTICLE; FLUID INTAKE; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; CHEMISTRY; CROSS REACTION; IMMUNOLOGY; LABORATORY DIAGNOSIS; PROCEDURES; SALIVA; SUBSTANCE ABUSE;

AMPHETAMINES; COCAINE; CODEINE; CROSS REACTIONS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; METHAMPHETAMINE; MORPHINE; OPIATE ALKALOIDS; SALIVA; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 77749341053     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.2.103     Document Type: Article

References (11)

1. T. Gunnar, K. Ariniemi, and P. Lillsunde. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J. Mass Spectrom. 40: 739-753 (2005).
2. S. Pichini, I. Altieri, P. Zuccaro, and R. Pacifici. Drug monitoring in nonconventional biological fluids and matrices. Clin. Pharmacokinet. 30: 211-228 (1996).
3. R.S. Niedbala, K. Kardos, T. Fries, A. Cannon, and A. Davis. Immunoassay for detection of cocaine/metabolites in oral fluids. J. Anal. Toxicol. 25: 62-68 (2001).
4. E.J. Cone. Saliva testing for drugs of abuse. Ann. N.Y. Acad. Sci. 694: 91-127 (1993).
5. E.J. Cone and M.A. Huestis. Interpretation of oral fluid tests for drugs of abuse. Ann. N.Y. Acad. Sci. 1098: 51-103 (2007).
6. Department of Health and Human Services. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed. Regist. 69: 19673-19732 (2004).
7. E.J. Cone, L. Presley, M. Lehrer, W. Seiter, M. Smith, K. Kardos, D. Fritch, S. Salamone, and R.S. Niedbala. Oral fluid testing for drugs of abuse: Positive prevalence rates by Intercept™ immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol. 26: 541-546 (2002).
8. E.J. Cone, J. Clarke, and L. Tsanaclis. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J. Anal. Toxicol. 31: 424-433 (2007).
9. K. Blum, S. Nonnemacher, D. Fritch, B.J. Haggerty, M.P. Sullivan, and E.J. Cone. Identification and quantitation of opiates, cocaine, amphetamines and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 33(9): 569-577 (2009).
10. R.J. Schepers, J.M. Oyler, R.E. Joseph, Jr., E.J. Cone, E.T. Moolchan, and M.A. Huestis. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 49: 121-132 (2003).
11. L. Presley, M. Lehrer,W. Seiter, D. Hahn, B. Rowland, M. Smith, K.W. Kardos, D. Fritch, S. Salamone, R.S. Niedbala, and E.J. Cone. High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens. Forensic Sci. Int. 133: 22-25 (2003).